COVID-19 VACCINE: BHARAT BIOTECH'S ‘COVAXIN’ ALL SET FOR PHASE I, II HUMAN TRIALS

Highlights

• COVAXIN has shown extremely positive results in preclinical trials in terms of safety and effective immune responses

• Bharat Biotech is working on the development of the COVID-19 vaccine in association with the ICMR (Indian Council for Medical Research)

• According to the statement issues by the WHO, AstraZeneca is leading the race to develop first effective COVID-19 vaccine

....